清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

医学 肝细胞癌 阿帕蒂尼 内科学 胃肠病学 放射科 门静脉 多中心研究 血栓 肿瘤科 癌症 随机对照试验
作者
Wei-Li Xia,Xiao-Hui Zhao,Yuan Guo,Hongtao Hu,Guangshao Cao,Zhen Li,Weijun Fan,Shi‐Jun Xu,Hai-Liang Li
出处
期刊:Clinical and translational gastroenterology [American College of Gastroenterology]
卷期号:14 (5): e00581-e00581 被引量:14
标识
DOI:10.14309/ctg.0000000000000581
摘要

INTRODUCTION: The aim of this study was to compare transarterial chemoembolization (TACE) combined with apatinib and PD-1 inhibitors (TACE-AP) with TACE combined with apatinib alone (TACE-A) in the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) and to explore the prognostic factors affecting the survival of patients. METHODS: This retrospective study analyzed data of patients with HCC with PVTT who were treated with TACE-AP or TACE-A between December 2018 and June 2021. The primary end points of the study were progression-free survival (PFS) and overall survival (OS), and the secondary end points were objective response rate (ORR) and adverse events (AEs). Propensity score matching (PSM) and stabilized inverse probability weighting (sIPTW) analyses were used to reduce patient selection bias, and Cox regression analysis was used to analyze prognostic factors affecting patient survival. RESULTS: Sixty-nine and 40 patients were included in the TACE-A and TACE-AP groups, respectively. After PSM and IPTW analyses, the median PFS and median OS in the TACE-AP group were significantly higher than those in the TACE-A group (PFS: after PSM, 6.9 vs 4.0 months, P < 0.001, after IPTW, 6.5 vs 5.1 months, P < 0.001; OS: after PSM, 14.6 vs 8.5 months P < 0.001, after IPTW, 16.1 vs 10.5 months, P < 0.001). After PSM and IPTW analyses, the tumor ORR in the TACE-AP group was significantly higher than that in the TACE-A group (PSM, 53.6% vs 17.9%, P = 0.005; IPTW, 52.5% vs 28.6%, P = 0.013). All treatment-related AEs were observed to be tolerated. Multivariate Cox regression analysis showed that the main prognostic factors affecting the survival of patients were tumor number, PVTT type, alpha-fetoprotein, and treatment mode. DISCUSSION: In the treatment of patients with HCC with PVTT, TACE-AP significantly improved PFS, OS, and ORR, and the AEs were safe and controllable.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
氿瑛完成签到,获得积分10
2秒前
科研通AI6应助科研通管家采纳,获得10
13秒前
科研通AI6应助科研通管家采纳,获得10
13秒前
奶奶的龙应助科研通管家采纳,获得10
13秒前
华仔应助科研通管家采纳,获得10
13秒前
21秒前
xiang完成签到,获得积分20
50秒前
1分钟前
2分钟前
2分钟前
奶奶的龙应助科研通管家采纳,获得10
2分钟前
奶奶的龙应助科研通管家采纳,获得10
2分钟前
科研通AI6应助科研通管家采纳,获得10
2分钟前
hu完成签到,获得积分10
2分钟前
2分钟前
2分钟前
hu发布了新的文献求助10
2分钟前
2分钟前
2分钟前
大雁完成签到 ,获得积分0
3分钟前
老老熊完成签到,获得积分10
3分钟前
Una完成签到,获得积分10
3分钟前
合作完成签到 ,获得积分10
3分钟前
欣欣完成签到,获得积分10
3分钟前
一天完成签到 ,获得积分10
3分钟前
甜甜的静柏完成签到 ,获得积分10
4分钟前
科研通AI6应助科研通管家采纳,获得10
4分钟前
科研通AI6应助科研通管家采纳,获得10
4分钟前
奶奶的龙应助科研通管家采纳,获得30
4分钟前
sujingbo完成签到 ,获得积分10
4分钟前
4分钟前
5分钟前
5分钟前
5分钟前
5分钟前
你好完成签到 ,获得积分10
5分钟前
5分钟前
结实的寒梦完成签到,获得积分10
5分钟前
量子星尘发布了新的文献求助10
5分钟前
尚青华完成签到 ,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
Les Mantodea de guyane 2000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
Cummings Otolaryngology Head and Neck Surgery 8th Edition 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5755732
求助须知:如何正确求助?哪些是违规求助? 5498033
关于积分的说明 15381526
捐赠科研通 4893640
什么是DOI,文献DOI怎么找? 2632305
邀请新用户注册赠送积分活动 1580173
关于科研通互助平台的介绍 1536016